Deatrick Kristopher B, Eliason Jonathan L, Lynch Erin M, Moore Andrea J, Dewyer Nicholas A, Varma Manu R, Pearce Charles G, Upchurch Gilbert R, Wakefield Thomas W, Henke Peter K
Jobst Vascular Laboratory, Section of Vascular Surgery, University of Michigan Medical School, Ann Arbor, 48109, USA.
J Vasc Surg. 2005 Jul;42(1):140-8. doi: 10.1016/j.jvs.2005.04.014.
Deep venous thrombosis (DVT) confers vein wall injury associated with fibrosis and extracellular matrix (ECM) turnover, likely mediated by matrix proteases. This study investigated the expression of proteases and collagen involved in early vein wall remodeling.
In the mouse, DVT was produced by ligation of the infrarenal inferior vena cava (IVC) or sham operation, and tissue was harvested at 4, 8, and 12 days. The vein wall tissue was processed for real-time reverse transcriptase-polymerase chain reaction (6 to 8 per time point), Western immunoblotting (5 per time point), and gelatin zymography (5 per time point). Analysis of variance was used for multiple comparisons, and a P < .05 was significant.
Thrombus resolution was documented by a 38% decrease in the thrombosed IVC weight from day 4 to day 12 (P = .007). Total vein wall collagen increased over time, with a corresponding increase in procollagen I and III, and expression peaked at 12 days (24-fold and 6.1-fold, respectively, P < .02). Matrix metalloproteinase-2 (MMP-2) gene expression was 23-fold greater at 12 days after thrombus formation compared with sham or 4 days after thrombosis (P < .05). Total MMP-2 activity was also significantly elevated at 12 days compared with sham (P < .05). MMP-9 expression was 19-fold and 27-fold higher at days 4 and 8, respectively, relative to sham (P < .05), with no difference in activity. MMP-14 expression was twofold to 3.6-fold greater at day 12 compared with earlier time points and shams (P < .001), but no differences in protein levels were found. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) protein levels were not significantly different from sham over time; however, the ratio of uPA to PAI-1 was decreased through 8 days.
Vein wall remodeling after DVT is similar to wound healing and is associated with increased procollagen gene expression and total collagen. It is also associated with increased early MMP-9 expression, followed by MMP-2 expression and activity after DVT resolution.
Deep vein thrombosis is an often neglected problem that long term is associated with the postphlebitic syndrome of limb swelling, pain, and often ulceration. The basic mechanisms of the vein wall damage that results have not been delineated. The following study describes the vein wall matrix metalloproteinase gene and activity response induced over time in the vein wall after DVT. Additionally, the corresponding collagen upregulation and proximate plasmin system mediators are determined. With this knowledge, potential therapies to reduce vein wall injury directly might be possible.
深静脉血栓形成(DVT)会导致与纤维化和细胞外基质(ECM)周转相关的静脉壁损伤,可能由基质蛋白酶介导。本研究调查了参与早期静脉壁重塑的蛋白酶和胶原蛋白的表达。
在小鼠中,通过结扎肾下腔静脉(IVC)或假手术制造DVT,并在4天、8天和12天时采集组织。对静脉壁组织进行实时逆转录聚合酶链反应(每个时间点6至8个样本)、蛋白质免疫印迹(每个时间点5个样本)和明胶酶谱分析(每个时间点5个样本)。采用方差分析进行多重比较,P <.05具有显著性。
从第4天到第12天,血栓形成的IVC重量减少了38%,证明血栓溶解(P =.007)。静脉壁总胶原蛋白随时间增加,前胶原蛋白I和III相应增加,且表达在12天时达到峰值(分别增加24倍和6.1倍,P <.02)。与假手术组或血栓形成后4天相比,血栓形成后12天基质金属蛋白酶-2(MMP-2)基因表达增加23倍(P <.05)。与假手术组相比,12天时总MMP-2活性也显著升高(P <.05)。与假手术组相比,MMP-9在第4天和第8天的表达分别高19倍和27倍(P <.05),活性无差异。与早期时间点和假手术组相比,MMP-14在第12天的表达增加2至3.6倍(P <.001),但蛋白质水平无差异。尿激酶型纤溶酶原激活剂(uPA)和纤溶酶原激活剂抑制剂-1(PAI-1)的蛋白质水平随时间与假手术组无显著差异;然而,uPA与PAI-1的比值在8天内降低。
DVT后的静脉壁重塑类似于伤口愈合,与前胶原蛋白基因表达增加和总胶原蛋白增加有关。它还与早期MMP-9表达增加有关,随后在DVT溶解后MMP-2表达和活性增加。
深静脉血栓形成是一个常被忽视的问题,长期与肢体肿胀、疼痛且常伴有溃疡的静脉炎后综合征相关。导致这种情况的静脉壁损伤的基本机制尚未明确。以下研究描述了DVT后静脉壁中基质金属蛋白酶基因和活性随时间的诱导反应。此外,还确定了相应的胶原蛋白上调和纤溶系统近端介质。有了这些知识,可能有可能直接减少静脉壁损伤的潜在治疗方法。